AARP's Lobbying For Drug Cost Controls Gets Spotlight At House Hearing
This article was originally published in The Pink Sheet Daily
Executive Summary
Subcommittee session serves as platform for advocacy group's pitch for closing the Medicare Part D coverage gap.
You may also be interested in...
Rx Price Hikes In Advance Of Health Bill Will Get OIG Probe
Sen. Bill Nelson continues campaign to extract more concessions from pharmaceutical industry as part of health care reform legislation.
Rx Price Hikes In Advance Of Health Bill Will Get OIG Probe
Sen. Bill Nelson continues campaign to extract more concessions from pharmaceutical industry as part of health care reform legislation.
Battle Over Part D Rebates Gets Tougher: AARP Endorses House Bill
The pharmaceutical industry's campaign against legislation mandating drug rebates for low-income beneficiaries covered by Medicare Part D has gotten more challenging